ALVOPDUFA
AVT05 (Proposed Biosimilar to Simponi® & Simponi Aria® (golimumab))
Inflammatory disease
Approval decisionFDA regulatory calendar
Track FDA action dates and advisory committee meetings by month. Each event links to its company, drug, indication and source-backed research record.
FDA regulatory calendar
Inflammatory disease
Approval decisionEye disease
Approval decisionUse the monthly FDA calendar to review PDUFA target dates and advisory committee meetings, then open each event for drug, company, indication and source context.
Systemic Lupus Erythematosus
Approval decisionFirst-Line HER2-Positive Gastroesophageal Adenocarcinoma
Approval decisionHRR Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer
Approval decision